Global Nanoparticle-Mediated Delivery Market Research Report 2024(Status and Outlook)

Global Nanoparticle-Mediated Delivery Market Research Report 2024(Status and Outlook)



Report Overview:

Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.

In this report, we only study liposomal/lipid nanoparticle drug delivery system.

LNPs became more widely known in late 2020, as some COVID-19 vaccines that use RNA vaccine technology coat the fragile mRNA strands with PEGylated lipid nanoparticles as their delivery vehicle (including both the Moderna and the Pfizer–BioNTech COVID-19 vaccines).

In this report, the COVID-19 vaccines with lipid nanoparticles technologies are not covered. The COVID-19 vaccines launch on the end of 2020. We expect revenue for COVID-19 vaccines with lipid nanoparticles technologies in 2021 to be approximately 37 billion USD.

The Global Nanoparticle-Mediated Delivery Market Size was estimated at USD 4776.26 million in 2023 and is projected to reach USD 5939.65 million by 2029, exhibiting a CAGR of 3.70% during the forecast period.

This report provides a deep insight into the global Nanoparticle-Mediated Delivery market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nanoparticle-Mediated Delivery Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nanoparticle-Mediated Delivery market in any manner.

Global Nanoparticle-Mediated Delivery Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

AbbVie

BlueWillow Biologics

NovaSOL

Camurus

Ceramisphere

Celgene, CytImmune

Cristal Therapeutics

EnColl

Lena Nanoceutics Ltd.

EyePoint Pharmaceuticals

Nanobiotix

NanoCarrier

Nanospectra

NanOlogy

Selecta Biosciences

Parvus Therapeutics

Starpharma

Tarveda Therapeutics

Market Segmentation (by Type)

Biological Origin

Non-Biological Origin

Market Segmentation (by Application)

Drug Delivery

Gene Delivery

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Nanoparticle-Mediated Delivery Market

Overview of the regional outlook of the Nanoparticle-Mediated Delivery Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nanoparticle-Mediated Delivery Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Nanoparticle-Mediated Delivery
1.2 Key Market Segments
1.2.1 Nanoparticle-Mediated Delivery Segment by Type
1.2.2 Nanoparticle-Mediated Delivery Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Nanoparticle-Mediated Delivery Market Overview
2.1 Global Market Overview
2.1.1 Global Nanoparticle-Mediated Delivery Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Nanoparticle-Mediated Delivery Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Nanoparticle-Mediated Delivery Market Competitive Landscape
3.1 Global Nanoparticle-Mediated Delivery Sales by Manufacturers (2019-2024)
3.2 Global Nanoparticle-Mediated Delivery Revenue Market Share by Manufacturers (2019-2024)
3.3 Nanoparticle-Mediated Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nanoparticle-Mediated Delivery Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Nanoparticle-Mediated Delivery Sales Sites, Area Served, Product Type
3.6 Nanoparticle-Mediated Delivery Market Competitive Situation and Trends
3.6.1 Nanoparticle-Mediated Delivery Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nanoparticle-Mediated Delivery Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Nanoparticle-Mediated Delivery Industry Chain Analysis
4.1 Nanoparticle-Mediated Delivery Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Nanoparticle-Mediated Delivery Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Nanoparticle-Mediated Delivery Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nanoparticle-Mediated Delivery Sales Market Share by Type (2019-2024)
6.3 Global Nanoparticle-Mediated Delivery Market Size Market Share by Type (2019-2024)
6.4 Global Nanoparticle-Mediated Delivery Price by Type (2019-2024)
7 Nanoparticle-Mediated Delivery Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nanoparticle-Mediated Delivery Market Sales by Application (2019-2024)
7.3 Global Nanoparticle-Mediated Delivery Market Size (M USD) by Application (2019-2024)
7.4 Global Nanoparticle-Mediated Delivery Sales Growth Rate by Application (2019-2024)
8 Nanoparticle-Mediated Delivery Market Segmentation by Region
8.1 Global Nanoparticle-Mediated Delivery Sales by Region
8.1.1 Global Nanoparticle-Mediated Delivery Sales by Region
8.1.2 Global Nanoparticle-Mediated Delivery Sales Market Share by Region
8.2 North America
8.2.1 North America Nanoparticle-Mediated Delivery Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nanoparticle-Mediated Delivery Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nanoparticle-Mediated Delivery Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nanoparticle-Mediated Delivery Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nanoparticle-Mediated Delivery Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 AbbVie
9.1.1 AbbVie Nanoparticle-Mediated Delivery Basic Information
9.1.2 AbbVie Nanoparticle-Mediated Delivery Product Overview
9.1.3 AbbVie Nanoparticle-Mediated Delivery Product Market Performance
9.1.4 AbbVie Business Overview
9.1.5 AbbVie Nanoparticle-Mediated Delivery SWOT Analysis
9.1.6 AbbVie Recent Developments
9.2 BlueWillow Biologics
9.2.1 BlueWillow Biologics Nanoparticle-Mediated Delivery Basic Information
9.2.2 BlueWillow Biologics Nanoparticle-Mediated Delivery Product Overview
9.2.3 BlueWillow Biologics Nanoparticle-Mediated Delivery Product Market Performance
9.2.4 BlueWillow Biologics Business Overview
9.2.5 BlueWillow Biologics Nanoparticle-Mediated Delivery SWOT Analysis
9.2.6 BlueWillow Biologics Recent Developments
9.3 NovaSOL
9.3.1 NovaSOL Nanoparticle-Mediated Delivery Basic Information
9.3.2 NovaSOL Nanoparticle-Mediated Delivery Product Overview
9.3.3 NovaSOL Nanoparticle-Mediated Delivery Product Market Performance
9.3.4 NovaSOL Nanoparticle-Mediated Delivery SWOT Analysis
9.3.5 NovaSOL Business Overview
9.3.6 NovaSOL Recent Developments
9.4 Camurus
9.4.1 Camurus Nanoparticle-Mediated Delivery Basic Information
9.4.2 Camurus Nanoparticle-Mediated Delivery Product Overview
9.4.3 Camurus Nanoparticle-Mediated Delivery Product Market Performance
9.4.4 Camurus Business Overview
9.4.5 Camurus Recent Developments
9.5 Ceramisphere
9.5.1 Ceramisphere Nanoparticle-Mediated Delivery Basic Information
9.5.2 Ceramisphere Nanoparticle-Mediated Delivery Product Overview
9.5.3 Ceramisphere Nanoparticle-Mediated Delivery Product Market Performance
9.5.4 Ceramisphere Business Overview
9.5.5 Ceramisphere Recent Developments
9.6 Celgene, CytImmune
9.6.1 Celgene, CytImmune Nanoparticle-Mediated Delivery Basic Information
9.6.2 Celgene, CytImmune Nanoparticle-Mediated Delivery Product Overview
9.6.3 Celgene, CytImmune Nanoparticle-Mediated Delivery Product Market Performance
9.6.4 Celgene, CytImmune Business Overview
9.6.5 Celgene, CytImmune Recent Developments
9.7 Cristal Therapeutics
9.7.1 Cristal Therapeutics Nanoparticle-Mediated Delivery Basic Information
9.7.2 Cristal Therapeutics Nanoparticle-Mediated Delivery Product Overview
9.7.3 Cristal Therapeutics Nanoparticle-Mediated Delivery Product Market Performance
9.7.4 Cristal Therapeutics Business Overview
9.7.5 Cristal Therapeutics Recent Developments
9.8 EnColl
9.8.1 EnColl Nanoparticle-Mediated Delivery Basic Information
9.8.2 EnColl Nanoparticle-Mediated Delivery Product Overview
9.8.3 EnColl Nanoparticle-Mediated Delivery Product Market Performance
9.8.4 EnColl Business Overview
9.8.5 EnColl Recent Developments
9.9 Lena Nanoceutics Ltd.
9.9.1 Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Basic Information
9.9.2 Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Product Overview
9.9.3 Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Product Market Performance
9.9.4 Lena Nanoceutics Ltd. Business Overview
9.9.5 Lena Nanoceutics Ltd. Recent Developments
9.10 EyePoint Pharmaceuticals
9.10.1 EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Basic Information
9.10.2 EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Product Overview
9.10.3 EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Product Market Performance
9.10.4 EyePoint Pharmaceuticals Business Overview
9.10.5 EyePoint Pharmaceuticals Recent Developments
9.11 Nanobiotix
9.11.1 Nanobiotix Nanoparticle-Mediated Delivery Basic Information
9.11.2 Nanobiotix Nanoparticle-Mediated Delivery Product Overview
9.11.3 Nanobiotix Nanoparticle-Mediated Delivery Product Market Performance
9.11.4 Nanobiotix Business Overview
9.11.5 Nanobiotix Recent Developments
9.12 NanoCarrier
9.12.1 NanoCarrier Nanoparticle-Mediated Delivery Basic Information
9.12.2 NanoCarrier Nanoparticle-Mediated Delivery Product Overview
9.12.3 NanoCarrier Nanoparticle-Mediated Delivery Product Market Performance
9.12.4 NanoCarrier Business Overview
9.12.5 NanoCarrier Recent Developments
9.13 Nanospectra
9.13.1 Nanospectra Nanoparticle-Mediated Delivery Basic Information
9.13.2 Nanospectra Nanoparticle-Mediated Delivery Product Overview
9.13.3 Nanospectra Nanoparticle-Mediated Delivery Product Market Performance
9.13.4 Nanospectra Business Overview
9.13.5 Nanospectra Recent Developments
9.14 NanOlogy
9.14.1 NanOlogy Nanoparticle-Mediated Delivery Basic Information
9.14.2 NanOlogy Nanoparticle-Mediated Delivery Product Overview
9.14.3 NanOlogy Nanoparticle-Mediated Delivery Product Market Performance
9.14.4 NanOlogy Business Overview
9.14.5 NanOlogy Recent Developments
9.15 Selecta Biosciences
9.15.1 Selecta Biosciences Nanoparticle-Mediated Delivery Basic Information
9.15.2 Selecta Biosciences Nanoparticle-Mediated Delivery Product Overview
9.15.3 Selecta Biosciences Nanoparticle-Mediated Delivery Product Market Performance
9.15.4 Selecta Biosciences Business Overview
9.15.5 Selecta Biosciences Recent Developments
9.16 Parvus Therapeutics
9.16.1 Parvus Therapeutics Nanoparticle-Mediated Delivery Basic Information
9.16.2 Parvus Therapeutics Nanoparticle-Mediated Delivery Product Overview
9.16.3 Parvus Therapeutics Nanoparticle-Mediated Delivery Product Market Performance
9.16.4 Parvus Therapeutics Business Overview
9.16.5 Parvus Therapeutics Recent Developments
9.17 Starpharma
9.17.1 Starpharma Nanoparticle-Mediated Delivery Basic Information
9.17.2 Starpharma Nanoparticle-Mediated Delivery Product Overview
9.17.3 Starpharma Nanoparticle-Mediated Delivery Product Market Performance
9.17.4 Starpharma Business Overview
9.17.5 Starpharma Recent Developments
9.18 Tarveda Therapeutics
9.18.1 Tarveda Therapeutics Nanoparticle-Mediated Delivery Basic Information
9.18.2 Tarveda Therapeutics Nanoparticle-Mediated Delivery Product Overview
9.18.3 Tarveda Therapeutics Nanoparticle-Mediated Delivery Product Market Performance
9.18.4 Tarveda Therapeutics Business Overview
9.18.5 Tarveda Therapeutics Recent Developments
10 Nanoparticle-Mediated Delivery Market Forecast by Region
10.1 Global Nanoparticle-Mediated Delivery Market Size Forecast
10.2 Global Nanoparticle-Mediated Delivery Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Nanoparticle-Mediated Delivery Market Size Forecast by Country
10.2.3 Asia Pacific Nanoparticle-Mediated Delivery Market Size Forecast by Region
10.2.4 South America Nanoparticle-Mediated Delivery Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Nanoparticle-Mediated Delivery by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Nanoparticle-Mediated Delivery Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Nanoparticle-Mediated Delivery by Type (2025-2030)
11.1.2 Global Nanoparticle-Mediated Delivery Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Nanoparticle-Mediated Delivery by Type (2025-2030)
11.2 Global Nanoparticle-Mediated Delivery Market Forecast by Application (2025-2030)
11.2.1 Global Nanoparticle-Mediated Delivery Sales (K Units) Forecast by Application
11.2.2 Global Nanoparticle-Mediated Delivery Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings